• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Kimball Electronics, Inc. Announces Appointment of Additional Director

    9/15/22 4:05:00 PM ET
    $BHC
    $KE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Electrical Products
    Technology
    Get the next $BHC alert in real time by email

    Kimball Electronics, Inc. (NASDAQ:KE), announces the expansion of its Board of Directors and appointment of a new director at its regularly scheduled Board Meeting on September 13, 2022.

    Tom Vadaketh was selected to the Company's Board of Directors (the "Board"), effective as of the September meeting. Mr. Vadaketh will serve on the Audit Committee and will stand for election to a full term at the 2022 Annual Meeting of Share Owners in November.

    Mr. Vadaketh serves as Chief Financial Officer of Bausch Health (NYSE:BHC) (TSX:BHC), which develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices globally, primarily in the therapeutic areas of eye-health, gastroenterology, and dermatology.

    Prior to joining Bausch Health in January 2022, Mr. Vadaketh served as Executive Vice President and Chief Financial Officer of eResearch Technology, Inc. from September 2018 to December 2021, where he was responsible for leading the Finance function including controllership, treasury, taxation, and financial planning.

    Prior to that, he was Executive Vice President and Chief Financial Officer of Cambrex Corporation. In addition, Mr. Vadaketh spent over 20 years at Procter & Gamble and Tyco International, where he held several roles of increasing responsibility at both companies.

    Mr. Vadaketh received a degree from the Institute of Chartered Accountants in England and Wales (ACA) and an M.B.A. from Manchester Business School. He is a Certified Public Accountant.

    "Speaking on behalf of our Board, it is an honor to have Tom join us with his well-rounded financial expertise, vast experience with major multinational organizations, and demonstrated leadership in a variety of global businesses driving both organic growth and strategic acquisitions," said Don Charron, Chairman of the Board and Chief Executive Officer. "Tom further enhances our Board's distinct and valuable skill sets as we continue to build lasting relationships and global success with our stakeholders. We expect to learn a lot from Tom so that we become an even better company while creating quality for life."

    About Kimball Electronics, Inc.

    Kimball Electronics is a multifaceted manufacturing solutions provider of electronics and diversified contract manufacturing services to customers around the world. From our operations in the United States, China, India, Japan, Mexico, Poland, Romania, Thailand, and Vietnam, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values personal and organizational commitment to quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (NASDAQ:KE) is headquartered in Jasper, Indiana.

    To learn more about Kimball Electronics, visit: www.kimballelectronics.com.

    Lasting relationships. Global success.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005963/en/

    Get the next $BHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BHC
    $KE

    CompanyDatePrice TargetRatingAnalyst
    Bausch Health Companies Inc.
    $BHC
    12/9/2025$8.00Equal Weight
    Barclays
    Kimball Electronics Inc.
    $KE
    8/15/2024Buy → Neutral
    Sidoti
    Bausch Health Companies Inc.
    $BHC
    8/2/2024$9.00 → $3.00Neutral → Underweight
    Piper Sandler
    Bausch Health Companies Inc.
    $BHC
    7/10/2024$8.00Mkt Perform
    Raymond James
    Kimball Electronics Inc.
    $KE
    10/9/2023$39.00Buy
    B. Riley Securities
    Bausch Health Companies Inc.
    $BHC
    9/20/2023$9.00 → $16.00Hold → Buy
    Jefferies
    Bausch Health Companies Inc.
    $BHC
    6/16/2023Outperform → Market Perform
    TD Cowen
    Kimball Electronics Inc.
    $KE
    6/15/2023$3.40Overweight
    Cantor Fitzgerald
    More analyst ratings

    $BHC
    $KE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Paulson & Co. Inc. bought $15,625,000 worth of shares (2,500,000 units at $6.25) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    11/28/25 5:38:39 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Paulson John bought $312,490,062 worth of shares (34,721,118 units at $9.00) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/14/25 9:35:28 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Paulson John bought $21,267,731 worth of shares (3,243,049 units at $6.56) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/13/25 6:51:24 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Director Phillips Richard D converted options into 7,673 shares and covered exercise/tax liability with 3,296 shares, increasing direct ownership by 6% to 82,188 units (SEC Form 4)

    4 - Kimball Electronics, Inc. (0001606757) (Issuer)

    1/6/26 2:30:07 PM ET
    $KE
    Electrical Products
    Technology

    Director Paulson John was granted 8,992 shares, increasing direct ownership by 3% to 360,120 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    1/2/26 4:08:45 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Leung Sandra was granted 4,586 shares, increasing direct ownership by 14% to 38,408 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    1/2/26 4:07:15 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kimball Electronics Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis

    Company Intends to Rebrand as Kimball Solutions as It Celebrates 65 Years of Excellence A legacy of innovation continues with a new name and expanded capabilities to serve customers globally Kimball Electronics, Inc. (NASDAQ:KE) today announced the date for the ribbon-cutting ceremony at its new medical manufacturing facility in Indianapolis. On Friday, February 6, 2026, Kimball executives, local officials, and community leaders will gather at the new facility located at 1220 Post Road, Indianapolis, IN, to celebrate the opening of Kimball's advanced manufacturing and innovation hub serving the medical and life sciences industries. The event is scheduled to start at 10:00 AM Eastern Tim

    1/8/26 4:05:00 PM ET
    $KE
    Electrical Products
    Technology

    Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

    LAVAL, QC, Jan. 5, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Thomas J. Appio, Chief Executive Officer, will participate at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 14, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website. Jean-Jacques (JJ) Charhon, EVP, Chief Financial Officer, and Jonathan Sadeh, M.D., EVP, Chief Medical Officer and Head of R&D will also be in attendance. Details Date: Wednesday, January 14, 2026 Time: 3:45 p.m. U.S. PT / 6:45 p.m. U.S. ET Webcast: http://ir.bauschhealth.com/events-and-presentations A replay of

    1/5/26 7:00:00 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kimball Electronics Intensifies Focus on Strategic Development With Appointment of a New Member to Its Leadership Team; Company to Participate at the Piper Sandler 37th Annual Healthcare Conference

      Kimball Electronics, Inc. (NASDAQ:KE) today announced the Company is intensifying its focus on strategic development with the appointment of a new member to its leadership team. Andrew D. Regrut, Treasurer and Investor Relations Officer, will now also lead the strategic development efforts of the Company. Commenting on Mr. Regrut's expanded role, Jana T. Croom, Chief Financial Officer, stated, "I'm thrilled to be announcing Andy's promotion and addition to our leadership team. He has been instrumental in our recent efforts to optimize debt levels through improved working capital management and global cash movement. We look for his energy and intensity to elevate our focus on strategic d

    12/2/25 8:30:00 AM ET
    $KE
    Electrical Products
    Technology

    $BHC
    $KE
    SEC Filings

    View All

    Bausch Health Companies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Bausch Health Companies Inc. (0000885590) (Filer)

    1/13/26 7:01:27 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kimball Electronics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Kimball Electronics, Inc. (0001606757) (Filer)

    1/8/26 4:16:23 PM ET
    $KE
    Electrical Products
    Technology

    Bausch Health Companies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - Bausch Health Companies Inc. (0000885590) (Filer)

    1/2/26 4:15:47 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Bausch Health with a new price target

    Barclays initiated coverage of Bausch Health with a rating of Equal Weight and set a new price target of $8.00

    12/9/25 8:43:03 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kimball Electronics downgraded by Sidoti

    Sidoti downgraded Kimball Electronics from Buy to Neutral

    8/15/24 7:57:54 AM ET
    $KE
    Electrical Products
    Technology

    Bausch Health downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Bausch Health from Neutral to Underweight and set a new price target of $3.00 from $9.00 previously

    8/2/24 7:25:50 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Leadership Updates

    Live Leadership Updates

    View All

    Kimball Electronics Intensifies Focus on Strategic Development With Appointment of a New Member to Its Leadership Team; Company to Participate at the Piper Sandler 37th Annual Healthcare Conference

      Kimball Electronics, Inc. (NASDAQ:KE) today announced the Company is intensifying its focus on strategic development with the appointment of a new member to its leadership team. Andrew D. Regrut, Treasurer and Investor Relations Officer, will now also lead the strategic development efforts of the Company. Commenting on Mr. Regrut's expanded role, Jana T. Croom, Chief Financial Officer, stated, "I'm thrilled to be announcing Andy's promotion and addition to our leadership team. He has been instrumental in our recent efforts to optimize debt levels through improved working capital management and global cash movement. We look for his energy and intensity to elevate our focus on strategic d

    12/2/25 8:30:00 AM ET
    $KE
    Electrical Products
    Technology

    Bausch Health Appoints New Chief Medical Officer and Head of R&D

    LAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment of Jonathan Sadeh M.D., M.Sc as Executive Vice President, Chief Medical Officer and Head of R&D. This strategic addition to our leadership team underscores our commitment to innovation, excellence, and enriching lives.Jonathan brings a wealth of experience and a proven track record of success both as a physician-scientist and a leader in the pharmaceutical industry. With over 20 years of expertise in clinical research and drug development, he has consistently demonstrated the ability to drive growth and foster innovation. Most recently, at Bristol-Meyers Squibb,

    12/2/24 8:00:00 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PureTech Appoints Michele Holcomb, PhD, to Board of Directors

    Strategic healthcare leader brings more than 30 years of global experience to PureTech's Board following notable positions with Cardinal Health, Teva Pharmaceuticals and McKinsey & Company PureTech Health plc (NASDAQ:PRTC, LSE: PRTC))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb's appointment will take effect as of September 23, 2024. She brings more than 30 years of expertise leading global healthcare companies through strategic inflection points and preparing in

    8/22/24 2:00:00 AM ET
    $KE
    $PRTC
    Electrical Products
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Financials

    Live finance-specific insights

    View All

    Kimball Electronics Announces Date for Ribbon-Cutting Ceremony at New Medical Manufacturing Facility in Indianapolis

    Company Intends to Rebrand as Kimball Solutions as It Celebrates 65 Years of Excellence A legacy of innovation continues with a new name and expanded capabilities to serve customers globally Kimball Electronics, Inc. (NASDAQ:KE) today announced the date for the ribbon-cutting ceremony at its new medical manufacturing facility in Indianapolis. On Friday, February 6, 2026, Kimball executives, local officials, and community leaders will gather at the new facility located at 1220 Post Road, Indianapolis, IN, to celebrate the opening of Kimball's advanced manufacturing and innovation hub serving the medical and life sciences industries. The event is scheduled to start at 10:00 AM Eastern Tim

    1/8/26 4:05:00 PM ET
    $KE
    Electrical Products
    Technology

    Kimball Electronics Reports Q1 Results; Company Reiterates Guidance for Fiscal 2026

    First Quarter 2026 Highlights Revenue of $365.6 million, with strong year-over-year sales growth in the medical end-market vertical Operating income of $14.5 million, or 4.0% of net sales, adjusted OI of 4.8%, up 140 bps year-over-year Net income of $10.1 million, or $0.40 per diluted share, adjusted EPS of $0.49, more than double Q1 fiscal 2025 Cash from operations of $8.1 million, the seventh consecutive quarter of positive cash generation Debt of $138.0 million, down $9.5 million in the quarter, and borrowing capacity of $294.3 million Cash Conversion Days of 83, the lowest level in 3 years Invested $1.5 million to repurchase 49,000 shares of common stock Kimball Electron

    11/5/25 4:05:00 PM ET
    $KE
    Electrical Products
    Technology

    Kimball Electronics, Inc. Announces Date For Reporting First Quarter Fiscal Year 2026 Financial Results

    Kimball Electronics, Inc. (NASDAQ:KE) today announced that it will report first quarter fiscal year 2026 financial results on Wednesday, November 5, 2025, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, November 6, 2025, at 10:00 a.m. Eastern Time. The telephone number to access the conference call is 888-396-8049 / +1 416-764-8646. A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be archived at investors.kimballelectronics.com. About Kimball Electronics, Inc. Kimball Electronics is a global, multif

    10/22/25 3:00:00 PM ET
    $KE
    Electrical Products
    Technology

    $BHC
    $KE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Kimball Electronics Inc.

    SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)

    11/12/24 3:47:56 PM ET
    $KE
    Electrical Products
    Technology

    Amendment: SEC Form SC 13G/A filed by Kimball Electronics Inc.

    SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)

    11/4/24 11:46:47 AM ET
    $KE
    Electrical Products
    Technology

    SEC Form SC 13G filed by Bausch Health Companies Inc.

    SC 13G - Bausch Health Companies Inc. (0000885590) (Subject)

    8/30/24 6:12:52 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care